Edit

https://www.intercure.co/
Last activity: 11.11.2022
Active
Categories: BusinessFinTechInformationWebsite
The Investor Relations website contains information about InterCure's business for stockholders, potential investors, and financial analysts.
Mentions
14
Employees: 11-50
Founded date: 2008

Investors 1

DateNameWebsite
-Subversivesubversive...

Mentions in press and media 14

DateTitleDescription
11.11.2022InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY-
09.02.2022InterCure : Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth - Form 6-KInterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth Estimated revenue reaches over CAD$31 million (a record NIS 77 million) Anticipates continued increases in adjusted operating profit and EBITD...
04.01.2022InterCure : REPORT OF VOTING RESULTS - Form 6-KREPORT OF VOTING RESULTS Pursuant to National Instrument 51-102 Continuous Disclosure Obligations Section 11.3 HERZLIYA, ISRAEL - (December 30, 2021) Intercure Ltd. (the "Company") announces today the results of the Annual General...
03.12.2021InterCure : Announces European Expansion with International Cannabis Brand Cookies - Form 6-KInterCure Announces European Expansion with International Cannabis Brand Cookies Leading Global Cannabis Company InterCure Partners with Cookies to Open Retail Locations in Austria and the U.K. in Early 2022 NEW YORK, TORONTO, and HERZLIYA,...
03.12.2021InterCure : VIA SEDAR - Form 6-KVIA SEDAR Re: Amended Management Information Circular Please be advised that the management information circular dated November 24, 2021 (the "Circular") and filed on SEDAR on November 25, 2021 has been re-filed to correct the num...
17.11.2021InterCure : Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month - Form 6-KInterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month With addition of four new pharmacies, InterCure's dedicated chain GIVOL now has 20 locations across Israel NEW YORK, TORONTO, and HE...
16.11.2021InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ GrowthSeventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run rate of $100 million Adjusted EBITDA1 run rate of $23 million $85 million in cash Revenue growth expected to continue in the 4th quarter and...
16.11.2021InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per MonthWith addition of four new pharmacies, InterCure’s dedicated chain GIVOL now has 20 locations across Israel NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR)...
25.10.2021InterCure : Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ GrowthAchieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutive quarter of high digit accelerated profitable growth Record quarterly EBITDA Commenced trading on NASDAQ in Sep...
25.10.2021InterCure : Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ Growth - Form 6-KInterCure Announces Record Preliminary Third Quarter Revenue of CAD$24 million - 3 Times YOY and 36% QOQ Growth Achieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutiv...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In